In the wake of a liberal revolution, medical marijuana Toronto has fallen into paramount political favor among Canadian leaders and citizens alike. As exhibited by advanced trade in Vancouver, the distribution of marijuana is not in itself a groundbreaking development; marketing of the drug, before legalization, has been operational for decades. Rather, what is exceptional about cannabis marketing in this day and age lies in the development of a medically vindicated system of circulation. There is a clear demand for the product, yet an officially mandated method for assigning prescriptions has yet to be created. The roots of a blossoming drug market could not be clearer than in the sale of medical marijuana in Toronto.
Over the past two years alone, numerous clinics specializing in medical cannabis have taken root in the city of Toronto. Along with these clinics has arrived a tightly knit community among doctors collaborating together to determine pertinent treatment details, such as possible interactions between marijuana and previously prescribed drugs. These doctors, however, only ratify a patient’s medical need for cannabis products. Processing and distribution is often handled by larger, licensed companies unrelated to the clinic.
Clinics offering such prescriptions are maintained by highly trained professionals, as in any other clinical setting. The problem, however, is that medical marijuana and its purported uses is a direly under-researched field. Physicians even today are forced to base cannabinoid treatments off of scant research and limited, sometimes inconclusive studies. Naturally, risks are involved for patients seeking prescription dosages—and health care professionals are not the only individuals involved in the marijuana market.
More prolifically than clinics and companies approved by Health Canada, independent dispensaries have become commonplace in Toronto. In the case of dispensaries, there is little regulation
at all. Some function as connections to licensed doctors, pointing prospective patients in directions that suit their needs. Others are solely profit-based, selling or prescribing marijuana regardless of how authentic the client’s condition may be.
This disparity in operations makes it difficult for medical and governmental agencies to determine the best course of regulation. What constitutes a need for a prescription, even, is not clear among marijuana providers. In addition to free reign dispensaries, private dealers are thriving in this era of legalization, pandering to recreational use alone. Supporters of medical legalization largely agree that some level of regulation is necessary, but plans for doing so have yet to become a federal or local endeavor.
Any drug, however advantageous, can become dangerous when left unchecked by a certified body of experts. If marijuana is to be issued for medical purposes, it will need to be treated with the reverence and caution of any other legally distributed drug.